About R. Van Allen
Form D filings for Cornovus Pharmaceuticals in 2024 list R. Van Allen as chief operating officer.
R. Van Allen first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name R. Van Allen in the role, so the role may have started earlier or lasted longer.